Medicine News and Research

RSS

Study: Interbacterial toxins may contribute to bacterial genetic diversity

A toxin produced by bacteria as a defence mechanism causes mutations in target bacteria that could help them survive, according to a study published today in eLife.

23 Feb 2021

AMP survey results indicate significant decline in molecular diagnostic testing

The Association for Molecular Pathology (AMP), the premier global, molecular diagnostic professional society, today released the preliminary results of its "Molecular Testing for Cancer during COVID-19" survey of clinical laboratories.

23 Feb 2021

Study reports a positive link between social vulnerability and COVID-19 incidence

An LSU Health New Orleans School of Public Health study reports a positive association between social vulnerability and COVID-19 incidence at the census tract level and recommends that more resources be allocated to socially vulnerable populations to reduce the incidence of COVID-19.

23 Feb 2021

Slight differences can help distinguish between two similar pediatric brain conditions

Slight differences in clinical features can help physicians distinguish between two rare but similar forms of autoimmune brain inflammation in children, a new study by UT Southwestern scientists suggests.

23 Feb 2021

Study reveals new routes to potential treatments for chronic inflammatory conditions

Inflammatory lung diseases such as asthma, COPD and, most recently, COVID-19, have proven difficult to treat.

23 Feb 2021

Large-scale whole genome sequencing in the Middle Eastern population reveals genetic risk factors

A group of researchers at Qatar Foundation have reported the first and largest genetic association study in the Middle East, that has been published online in Nature Communications - a leading a peer-reviewed, open access, scientific journal published by Nature Research.

23 Feb 2021

Polygenic hazard score improves prediction of prostate cancer risk in multi-ethnic populations

Building upon previous research, an international team led by scientists at University of California San Diego School of Medicine, has validated a more inclusive and comprehensive genetic tool for predicting age of onset of aggressive prostate cancer, a disease that killed more than 33,000 American men in 2020.

23 Feb 2021

Limiting the release of fat into the bloodstream during heart failure could help improve outcomes

University of Alberta researchers have found that limiting the amount of fat the body releases into the bloodstream from fat cells during heart failure could help improve outcomes for patients.

23 Feb 2021

New rapid diagnostic tests can differentiate between COVID-19 variants and multiple viruses

University of Minnesota Medical School researchers have developed two new rapid diagnostic tests for COVID-19 - one to detect COVID-19 variants and one to help differentiate with other illnesses that have COVID-19-like symptoms.

23 Feb 2021

Researchers develop models to predict epidemics of yellow fever, other mosquito-borne diseases

Yellow fever was the first human disease to have a licensed vaccine and has long been considered important to an understanding of how epidemics happen and should be combated.

23 Feb 2021

New gene-editing tool enables programming of sequential cuts over time

Researchers from the University of Illinois Chicago have discovered a new gene-editing technique that allows for the programming of sequential cuts -- or edits -- over time.

23 Feb 2021

MUSC physician wins $9.9 million contract to run trials for the Tuberculosis Trials Consortium

Susan Dorman, M.D., an infectious disease physician at the Medical University of South Carolina, was recently awarded a 10-year, $9.9 million contract by the Centers for Disease Control and Prevention to run trials for the Tuberculosis Trials Consortium.

23 Feb 2021

Hormone known to prevent weight gain can help maintain healthy muscles in mice

A new study suggests that a hormone known to prevent weight gain and normalize metabolism can also help maintain healthy muscles in mice.

23 Feb 2021

Study identifies potential therapeutic target for treatment of Huntington's disease

Huntington's disease is caused by a mutation in the Huntingtin gene (HTT), which appears in adults and features motor, cognitive and psychiatric alterations.

23 Feb 2021

Incidence of cardiometabolic and pulmonary events in UK has lowered due to COVID-19

A team of researchers from the University of Oxford, the London School of Hygiene and Tropical Medicine and other institutions recently analyzed extensive data collected by NHS England to reveal any association between SARS-CoV-2 infection and cardiometabolic or respiratory events.

23 Feb 2021

mRNA Therapeutics – Analytical and Bioanalytical Characterization

NewsMed interviews Anette Bak from AstraZeneca about her research on developments in mRNA therapeutics that she will present at Pittcon 2021.

From Pittcon 23 Feb 2021

Scientists identify new compound that reverses ALS neuron damage

Northwestern University scientists have identified the first compound that eliminates the ongoing degeneration of upper motor neurons that become diseased and are a key contributor to ALS (amyotrophic lateral sclerosis), a swift and fatal neurodegenerative disease that paralyzes its victims.

23 Feb 2021

Propranolol can be used to treat cerebral cavernous malformations

Propranolol, a drug that is efficacious against infantile haemangiomas ("strawberry naevi", resembling birthmarks), can also be used to treat cerebral cavernous malformations, a condition characterized by misshapen blood vessels in the brain and elsewhere.

23 Feb 2021

Maturation of 'mini brain' organoids matches human brain development

A new study from UCLA and Stanford University researchers finds that three-dimensional human stem cell-derived 'mini brain' organoids can mature in a manner that is strikingly similar to human brain development.

23 Feb 2021

Study findings help explain the diversity of cancers in different Li-Fraumeni patients

The most frequently mutated gene in human cancers is called p53. Patients with Li-Fraumeni syndrome, which is a rare disorder that increases the risk of developing several types of cancer, often have an increased risk to develop cancers at early ages if they inherit p53 mutations.

23 Feb 2021

Medicine News and Research

Study: Interbacterial toxins may contribute to bacterial genetic diversity

AMP survey results indicate significant decline in molecular diagnostic testing

Study reports a positive link between social vulnerability and COVID-19 incidence

Slight differences can help distinguish between two similar pediatric brain conditions

Study reveals new routes to potential treatments for chronic inflammatory conditions

Large-scale whole genome sequencing in the Middle Eastern population reveals genetic risk factors

Polygenic hazard score improves prediction of prostate cancer risk in multi-ethnic populations

Limiting the release of fat into the bloodstream during heart failure could help improve outcomes

New rapid diagnostic tests can differentiate between COVID-19 variants and multiple viruses

Researchers develop models to predict epidemics of yellow fever, other mosquito-borne diseases

New gene-editing tool enables programming of sequential cuts over time

MUSC physician wins $9.9 million contract to run trials for the Tuberculosis Trials Consortium

Hormone known to prevent weight gain can help maintain healthy muscles in mice

Study identifies potential therapeutic target for treatment of Huntington's disease

Incidence of cardiometabolic and pulmonary events in UK has lowered due to COVID-19

mRNA Therapeutics – Analytical and Bioanalytical Characterization

Scientists identify new compound that reverses ALS neuron damage

Propranolol can be used to treat cerebral cavernous malformations

Maturation of 'mini brain' organoids matches human brain development

Study findings help explain the diversity of cancers in different Li-Fraumeni patients

Everything there is to know about biosimilars eBook

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News